lightup
probe
technolog
matur
reach
phase
implement
commerci
reagent
kit
ie
ressq
product
line
sever
properti
lightup
probe
make
particularli
suitabl
clinic
set
instanc
extraordinari
shelf
life
chemic
stabil
allow
conveni
fridg
storag
origin
higher
stabil
lightup
probe
kit
compar
other
base
altern
probe
technolog
partli
rel
good
stabil
cyanin
dye
also
resist
toward
nucleas
proteas
synthet
dna
analogu
peptid
nucleic
acid
use
sequenc
recogn
element
lightup
probe
clear
recent
trend
pcr
amplif
hardwar
technolog
instrument
becom
flexibl
less
adapt
dedic
probe
chemistri
pave
way
increas
standard
field
dna
diagnost
develop
crossplatform
assay
present
review
lightup
technolog
briefli
present
discuss
util
technolog
illustr
exampl
cytomegaloviru
quantif
monitor
viral
load
sar
coronaviru
exampl
cancer
diagnost
detect
alter
gene
express
pattern
also
shown
use
realtim
pcr
molecular
diagnost
rapidli
gain
ground
becom
golden
standard
mani
instanc
particular
sensit
concern
quantif
desir
exampl
monitor
effect
antivir
treatment
mackay
et
al
mackay
mengoli
et
al
tanakakitajima
et
al
addit
advantag
detect
take
place
homogen
closedtub
format
mean
significantli
reduc
risk
carryov
contamin
compar
convent
method
foy
park
pcrbase
assay
particularli
sensit
robust
detect
quantif
dna
virus
due
high
conserv
genom
materi
differ
strain
combin
high
chemic
stabil
deoxyribonucl
acid
remark
sensit
pcr
singl
dna
copi
detect
optim
assay
make
extract
procedur
limit
factor
diagnost
set
rather
pcrcoupl
detect
step
fafikrem
et
al
schuurman
et
al
uhl
et
al
howev
even
nucleic
acid
extract
success
sever
way
pcr
amplificationdetect
step
may
fail
among
target
primer
andor
probe
may
conserv
particularli
relev
infecti
diseas
diagnost
herrmann
et
al
nye
et
al
ii
fluoresc
probe
use
realtim
pcr
frequent
chemic
unstabl
may
degrad
recent
lightup
probe
construct
allevi
drawback
encount
pcr
base
diagnost
svanvik
et
al
b
leijon
accomplish
use
fluoresc
report
dye
coupl
oligom
dna
analogu
peptid
nucleic
acid
pna
flexibl
linker
fig
pna
uncharg
isomorph
dna
mimic
compos
n
glycin
subunit
nielsen
et
al
provid
strong
still
specif
bind
serv
sequenc
recogn
element
probe
fact
pna
remark
properti
exhibit
higher
sequenc
specif
term
melt
point
decreas
bound
dna
dna
egholm
et
al
shorter
probe
use
lightup
probe
technolog
compet
dna
base
probe
technolog
livak
et
al
tyagi
kramer
bernard
et
al
mackay
et
al
due
high
bind
affin
pna
augment
dye
interact
dna
thu
conserv
patch
found
easili
highli
vari
microbi
viral
genom
respect
lightup
probe
resembl
taqman
minor
groov
bind
mgb
probe
afonina
et
al
fluorophor
use
lightup
probe
asymmetr
cyanin
dye
fluoresc
probe
bind
target
dna
virtual
nonfluoresc
probe
free
solut
one
exampl
thiazol
orang
shown
fig
exampl
sybr
green
proprietari
dye
molecular
probe
inc
oregon
usa
boxto
dye
karlsson
et
al
karlsson
et
al
shown
fig
use
pna
import
sinc
dye
posit
charg
significantli
higher
background
signal
would
result
intern
bind
dye
dna
use
instead
pna
svanvik
et
al
class
fluoresc
dye
also
rel
stabl
ressq
kit
base
lightup
probe
store
fridg
rather
freezer
storag
typic
pcr
kit
dye
combin
pna
backbon
degrad
neither
nucleas
proteas
demidov
et
al
amount
stabl
probe
robust
assay
improv
stabil
ressq
product
line
nucleic
acid
standard
materi
provid
lyophil
dna
base
sequenc
recogn
fluoresc
probe
usual
util
fluorophor
quencher
pair
separ
amplif
process
taqman
probe
degrad
nucleas
activ
dna
polymeras
releas
fluorophor
sequenc
recogn
element
therebi
separ
quencher
fluoresc
emiss
occur
livak
et
al
molecular
beacon
achiev
goal
rearrang
secondari
structur
upon
hybrid
caus
separ
quencher
fluorophor
tyagi
kramer
fluoresc
reson
energi
transfer
fret
probe
work
slightli
differ
instead
acceptor
dye
function
quencher
emit
detect
fluoresc
two
probe
bind
adjac
target
dna
molecul
bernard
et
al
lightup
probe
work
differ
mechan
probe
singl
asymmetr
cyanin
dye
type
dye
releas
excit
energi
intern
motion
free
solut
condit
virtual
nonfluoresc
henc
selfquench
bound
dna
howev
dye
becom
brightli
fluoresc
due
motion
hindranc
bound
state
svanvik
et
al
immunosuppress
transplant
recipi
well
person
infect
human
immunodefici
viru
type
suscept
sever
cytomegaloviru
cmv
infect
furthermor
congenit
cmv
infect
high
morbid
rate
common
therefor
import
detect
condit
clinic
practic
transplant
recipi
cmv
load
use
indic
activ
cmv
diseas
monitor
effect
antivir
treatment
mengoli
et
al
kalpo
et
al
tanakakitajima
et
al
hiv
patient
risk
develop
cmv
diseas
report
directli
relat
quantiti
cmv
plasma
spector
et
al
spector
et
al
sever
commerci
test
avail
e
g
coba
amplicor
cmv
monitor
test
roch
diagnost
hybrid
captur
system
cmv
dna
test
digen
corp
cmv
assay
although
test
use
inhous
socal
homebrew
realtim
pcr
assay
come
increas
use
main
reason
superior
sensit
pcr
close
tube
format
realtim
pcr
minim
risk
crossov
contamin
possibl
reproduc
precis
viral
load
quantif
outlin
howev
result
homebrew
assay
often
reproduc
laboratori
consequ
need
standard
ressq
assay
lightup
technolog
hudding
sweden
new
line
commerci
kit
qualit
quantit
detect
viral
dna
clinic
sampl
tri
bridg
gap
provid
standard
test
built
lightup
probe
technolog
realtim
pcr
applic
quantif
obtain
compar
pcr
cycl
fluoresc
reach
certain
threshold
level
unknown
clinic
sampl
pcr
threshold
cycl
valu
sequenti
usual
fold
dilut
seri
standard
dna
fig
dynam
rang
reproduc
ressq
cmv
assay
illustr
standard
curv
obtain
quadrupl
repeat
two
run
slope
correspond
essenti
pcr
reaction
effici
standard
curv
perfectli
linear
standard
curv
interv
copiespcr
zweygberg
wirgart
et
al
qualiti
control
molecular
diagnost
qcmd
initi
wallac
serv
provid
refer
comparison
differ
diagnost
lab
well
commerci
kit
manufactur
end
qcmd
design
develop
qualiti
control
materi
profici
programm
tabl
reproduc
zweygberg
wirgart
et
al
quantif
qcmd
cmv
profici
panel
obtain
use
ressq
cmv
assay
shown
viral
load
measur
ressq
assay
close
qcmd
target
valu
panel
averag
deviat
furthermor
neg
control
confirm
without
falseposit
result
zweygberg
wirgart
collegu
also
use
ressq
assay
monitor
effect
antivari
treatment
compar
result
obtain
amplicor
cmv
monitor
assay
roch
diagnost
cmv
dna
load
monitor
one
allogen
bone
marrowtranspl
patient
period
day
fig
month
prophylact
valtrex
therapi
low
undetect
cmv
dna
level
viral
load
increas
significantli
day
continu
rise
determin
assay
patient
therefor
treat
cymeven
day
respond
resist
ganciclovir
suspect
patient
switch
foscavir
therapi
day
ganciclovir
resist
inde
verifi
subsequ
high
cmv
viral
load
success
suppress
foscavir
therapi
drug
well
toler
patient
therapi
interrupt
increas
level
cmv
detect
day
assay
suppress
second
foscavir
treatment
cours
event
clearli
reflect
viral
load
determin
method
yield
close
similar
result
show
ressq
assay
highli
use
tool
cmv
viral
load
monitor
zweygberg
wirgart
et
al
sever
acut
respiratori
syndrom
coronaviru
sarscov
envelop
singlestrand
positivesens
rna
viru
belong
famili
coronavirida
rota
et
al
first
identifi
fall
guangdong
provinc
china
epidem
sar
affect
countri
case
death
report
liu
sever
diseas
combin
rapid
spread
lack
specif
treatment
requir
develop
fast
sensit
diagnost
assay
donnelli
et
al
ressq
assay
develop
detect
specif
sarscov
gene
assay
use
collabor
swedish
institut
infecti
diseas
control
investig
nitric
oxid
inhibit
replic
cycl
sarscov
et
al
nitric
oxid
import
signal
molecul
cell
shown
inhibitori
effect
virus
adler
et
al
lane
et
al
pope
et
al
boucher
et
al
coleman
investig
inhibit
viral
rna
replic
process
sarscov
vero
cell
infect
sarscov
moi
hpi
cell
treat
lm
organ
donor
snitrosonacetylpenicillamin
snap
neg
control
nacetylpenicillamin
nap
lack
nodon
snitroso
group
lyse
trizol
differ
period
time
total
rna
isol
viral
rna
subsequ
quantifi
realtim
pcr
use
ressq
sar
assay
lightup
technolog
ab
stockholm
sweden
lightcycl
instrument
roch
diagnost
basel
switzerland
quantifi
armor
sar
rna
covnc
contain
nucleocapsid
gene
ambion
diagnost
use
quantif
standard
emeri
et
al
rna
use
synthes
cdna
superscript
iii
rnase
hrevers
transcriptas
system
ressq
sar
assay
use
fig
amplifi
detect
sequenti
dilut
copiespcr
ambion
armor
rna
standard
seen
three
replic
copiespcr
level
readili
detect
illustr
excel
sensit
assay
furthermor
standard
curv
calcul
dilut
data
pcr
effici
calcul
slope
standard
curv
close
fig
specif
assay
investig
use
extract
rna
sever
virus
known
caus
similar
clinic
symptom
templat
result
display
fig
conclud
ressq
sar
assay
crossreact
test
virus
final
fig
reproduc
et
al
shown
lm
nodonor
snap
significantli
inhibit
viral
rna
product
lm
nap
effect
result
provid
evid
inhibit
sar
coronaviru
also
illustr
util
ressq
sar
assay
viral
load
monitor
rna
viru
realtim
pcr
applic
diseas
monitor
measur
express
marker
gene
rel
refer
gene
expect
express
level
independ
diseas
state
also
unaffect
paramet
may
vari
among
patient
today
refer
gene
select
optim
refer
gene
panel
human
endogen
control
gene
panel
tataa
biocent
wwwtataacom
still
even
properli
select
refer
gene
usual
show
variat
among
sampl
add
experiment
uncertainti
diagnosi
use
lightup
probe
develop
altern
approach
detect
monitor
diseas
realtim
pcr
reli
stabl
express
refer
gene
et
al
instead
measur
rel
express
marker
gene
refer
gene
propos
measur
rel
express
two
marker
gene
reciproc
affect
diseas
condit
one
diseas
approach
applic
nonhodgkin
lymphoma
nhl
nhl
develop
blymphocyt
lineag
blymphocyt
produc
immunoglobulin
heavi
chain
either
kappa
iglj
lambda
iglk
light
chain
fig
blymphocyt
decid
earli
develop
light
chain
produc
healthi
human
bcell
produc
kappa
chain
produc
lambda
chain
henc
normal
lymphoid
tissu
contain
mixtur
bcell
iglj
iglk
express
ratio
expect
levi
et
al
lymphoma
like
malign
tumor
clonal
aris
one
transform
cell
lymphoma
tissu
domin
tumor
cell
consequ
iglj
iglk
ratio
chang
kappaproduc
tumor
result
higher
iglj
iglk
ratio
lambdaproduc
tumor
result
lower
ratio
surgic
lymph
node
biopsi
previous
untreat
patient
transport
oper
theatr
ice
waterchil
box
handl
laboratori
within
min
materi
studi
rapidli
frozen
dri
iceisopentan
store
fine
needl
aspir
suspend
rnalat
ambion
directli
time
sampl
collect
cell
suspens
store
rnalat
one
two
day
cell
collect
centrifug
store
frozen
part
tissu
fix
formalin
use
routin
diagnost
analysi
diagnosi
reach
combin
microscop
evalu
histolog
immunostain
sever
marker
includ
kappa
lambda
chain
ihc
case
flow
cytometri
sampl
classifi
lymphaden
malign
lymphoma
accord
revis
europeanamerican
lymphoma
real
classif
harri
et
al
rna
extract
use
fast
prep
system
fastrna
green
qbiogen
ten
microgram
total
rna
mix
lg
pdt
oligom
pharmacia
incub
min
first
strand
cdna
synthesi
perform
ad
moll
trishcl
ph
moll
kcl
mmoll
mgcl
moll
dtt
uml
mmlv
revers
transcriptas
life
technolog
uml
rna
guard
life
technolog
mmoll
deoxyribonuleotid
life
technolog
final
volum
incub
sampl
h
reaction
termin
incub
min
sampl
store
two
lightup
probe
hcctttttcccnh
igljlup
cctcctctctnh
iglklup
direct
pcr
amplif
product
constant
region
human
immunoglobulin
kappa
iglj
lambda
iglk
lightchain
respect
design
probe
homopyrimidin
sequenc
known
exhibit
larg
signal
enhanc
upon
target
bind
svanvik
et
al
probe
thiazol
orang
deriv
yl
methylenyl
quinolinium
iodid
label
attach
peptid
nucleic
acid
synthes
solid
phase
synthesi
purifi
twice
revers
phase
hplc
svanvik
et
al
probe
concentr
determin
spectroscop
assum
molar
absorpt
nm
moll
cm
igljlup
moll
cm
iglklup
svanvik
et
al
probe
design
melt
temperatur
anneal
elong
temperatur
pcr
pcr
system
design
bp
fragment
human
iglj
genbank
access
number
bp
fragment
human
iglk
genbank
access
number
compris
igljlup
iglklup
target
sequenc
respect
reaction
condit
optim
describ
elsewher
iglj
iglk
pcr
contain
mmoll
tri
ph
mmoll
nh
tween
u
jumpstart
tm
taq
dna
polymeras
antibodi
sigmaaldrich
ngll
bovin
serum
albumin
fermenta
specif
compon
iglj
pcr
mmoll
mgcl
mmoll
deoxyribonuleotid
sigmaaldrich
nmoll
primer
medprob
inc
nmoll
igljlup
iglk
pcr
mmoll
mgcl
mmoll
deoxyribonuleotid
nmoll
primer
nmoll
iglklup
primer
sequenc
iglj
tga
gca
aag
cag
act
acg
forward
ggg
gtg
agg
tga
aag
atg
revers
iglk
gag
cct
gac
gcc
tga
forward
att
gag
ggt
tta
ttg
agt
gca
revers
realtim
pcr
measur
lightcycl
roch
diagnost
use
thermocycl
program
min
preincub
follow
cycl
fluoresc
monitor
end
anneal
phase
use
nm
excit
nm
emiss
lightcycl
channel
amplif
curv
baselin
adjust
subtract
arithmet
averag
five
lowest
fluoresc
readout
valu
sampl
arithmet
baselin
adjust
lightcycl
softwar
threshold
set
valu
significantli
background
nois
number
cycl
requir
reach
level
c
determin
thirtytwo
patient
sampl
analyz
bcell
lymphoma
lightup
qpcr
assay
twenti
sampl
surgic
biopsi
collect
fine
needl
aspir
et
al
sampl
run
duplic
includ
neg
control
data
present
fig
scatter
plot
symbol
repres
one
sampl
posit
plot
coordin
ct
iglj
ct
iglk
correspond
number
cdna
molecul
purifi
templat
indic
logarithm
scale
opposit
axe
sampl
found
neg
ihc
analysi
shown
green
posit
sampl
shown
red
sampl
pink
arc
collect
fine
needl
aspir
rel
express
two
gene
given
et
al
rearrang
linear
form
et
al
henc
data
point
repres
neg
sampl
scatter
plot
fit
straight
line
repres
iglj
iglk
express
ratio
healthi
individu
approach
requir
iglj
iglk
express
ratio
known
fact
estim
ratio
iglj
iglk
light
chain
ratio
protein
product
ratio
correspond
mrna
could
differ
exampl
due
differ
translat
effici
mrna
origin
studi
author
estim
paramet
eq
detail
character
subset
sampl
situ
calibr
et
al
found
iglj
iglk
mrna
express
ratio
neg
sampl
inde
close
author
could
also
calcul
confid
interv
neg
sampl
confid
interv
indic
scatter
plot
dash
line
henc
neg
sampl
base
qpcr
result
expect
within
dash
line
posit
sampl
j
clonal
found
line
sampl
k
clonal
line
agreement
qpcr
posit
scatter
plot
ihc
color
classif
excel
fine
needl
aspir
found
arc
fig
agreement
perfect
even
though
sampl
contain
cell
therefor
much
mrna
high
predict
power
lightup
probe
iglj
vs
iglk
assay
demonstr
strength
design
assay
base
rel
express
two
reciproc
marker
gene
instead
compar
express
singl
marker
gene
refer
gene
recent
strategi
use
diagnos
mantl
cell
lymphoma
measur
express
ratio
jone
et
al
strategi
limit
two
marker
gene
number
marker
gene
use
compani
multid
analys
wwwmultids
develop
softwar
classifi
sampl
base
arbitrari
number
marker
gene
without
reli
refer
gene
identifi
characterist
express
pattern
lightup
probe
technolog
shown
use
monitor
viral
load
dna
viru
cytomegaloviru
rna
virus
sar
corona
viru
effect
antivir
treatment
nitric
oxid
readili
detect
noteworthi
lightup
probe
short
typic
residu
use
viral
diagnost
mutat
frequenc
often
high
long
conserv
region
may
rare
particularli
true
rna
virus
hiv
influenza
sar
lightup
probe
assay
also
shown
quantifi
rel
express
kappalambda
gene
way
allow
diagnosi
blymphocyt
monoclon
